In addition, the levels of tTG in patients with CeD co - occurring with APS were significantly lower than those in patients with CeD without APS comorbidity (P < 0.001), suggesting that the tTG level in CeD patients may not be associated with the incidence of autoimmune diseases. Here, TGM2 is linked to cranioectodermal dysplasia.